GDF15 and myelodysplastic syndrome: GDF15 measured with the LTIA device for automated inspection is a biomarker very useful for diagnosing MDs because of the following rationales: first, the specificity and sensitivity of the LTIA device are good enough for the frontline indication of individuals with suspected MDs.